In News

Follow this topic

Bookmark

Record learning outcomes

Nicotine replacement therapy brand NiQuitin has reformulated its 2mg and 4mg peppermint lozenges to coincide with the latest phase of the Tobacco and Related Products Regulation. NiQuitin Lozenges work to reduce cravings and nicotine withdrawal symptoms, says manufacturer Perrigo. They are available in two strengths that deliver different levels of therapeutic nicotine without the harmful chemicals found in tobacco smoke and allow smokers to step down their nicotine levels and dependency on cigarettes slowly, the company explains.

Perrigo: UKLOCustomerService@perrigo.com